About 700 reports

EXECUTIVE SUMMARY ##.

  • Cardiovascular Disease
  • Chronic Disease
  • APAC
  • World
  • Market Shares

The 2021-2026 World Outlook for Cardiovascular Disease (CVD) Treatments ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Cardiovascular Disease
  • Chronic Disease
  • Pathology
  • World
  • Demand

The 2021-2026 World Outlook for Cardiovascular Disease (CVD) Diagnostics ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Cardiovascular Disease
  • Chronic Disease
  • Pathology
  • World
  • Demand
  • B) US cardiovascular disease market size
  • A) Global cardiovascular disease market split

TABLE ##: CARDIOVASCULAR DISEASE DRUGS MARKET, US, SYSTOLIC AND DIASTOLIC BLOOD PRESSURE LEVEL A recording of ## per ##mmHg or higher supports a diagnosis of hypertension (stage ## or above).

  • Cardiovascular Disease
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Germany Incidence of Cardiovascular Diseases, 2013-2017, (In %)
  • Germany Deaths by Cardiovascular Diseases, 2013-2017

The increase in defect of one of the heart valves due to any external or internal factor is going to escalate the market.

  • Cardiovascular Disease
  • World
  • Abbott
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • JOHNSON & JOHNSON ACQUIRED BRISTOL-MYERS CARDIOVASCULAR DISEASE PROGRAM
  • INDONESIA ANTITHROMBOTIC DRUGS MARKET

IT IS ESTIMATED THAT ONE IN THREE FRENCH PEOPLE PRESENTS MAJOR RISK FACTORS FOR CARDIOVASCULAR DISEASE.

  • Blood Disease
  • Cardiovascular Disease
  • World
  • Forecast
  • Johnson & Johnson
  • INCREASE IN CARDIOVASCULAR DISEASE
  • INCREASING PROGRAMS FOR CARDIOVASCULAR DISEASES

Table ##.

  • Cardiovascular Disease
  • Forecast
  • Mylan Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • GLOBAL - DEATHS RELATED TO CARDIOVASCULAR DISEASES & FORECAST (MILLION), 2015 & 2030
  • CHARACTERISTICS OF AND OUTCOMES FOR OHCA

Home Healthcare ##.

  • Cardiovascular Disease
  • World
  • Asahi Kasei Corporation
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Prevalence of cardiovascular disease in Japan, In million
  • Prevalence of cardiovascular disease in Brazil, In Billion

THREATS OF SUBSTITUTES - LOW ##.

  • Cardiovascular Disease
  • World
  • Market Size
  • B. Braun Medical
  • Boston Scientific Corporation
  • Increased Awareness Programs for Cardiovascular Diseases
  • Increase in Cardiovascular Disease in Africa

According to the World Health Organization, cardiovascular diseases are number one cause of the death across the world.

  • Cardiovascular Disease
  • Forecast
  • Market Size
  • Abbott
  • Boston Scientific Corporation
  • Increase in Cardiovascular Disease in Africa
  • Rise in the Number of Cardiovascular Diseases

FIGURE ##. ##.

  • Cardiovascular Disease
  • Forecast
  • Market Size
  • BioTelemetry Inc.
  • Medicomp, Inc.
  • A) Global cardiovascular disease market split
  • B) US cardiovascular disease market split

Clinical Hypertension; ##(##): ##.

  • Cardiovascular Disease
  • Market Size
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi S.A.
  • PREVALENCE OF CARDIOVASCULAR DISEASES IN UNITED STATES, IN MILLION
  • PREVALENCE OF CARDIOVASCULAR DISEASE IN FRANCE, IN THOUSANDS

THREATS OF SUBSTITUTES - LOW ##.

  • Cardiovascular Disease
  • World
  • B. Braun Medical
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Prevalence of cardiovascular disease in Japan, In million
  • Prevalence of cardiovascular disease in China, In million

SUPPLIER POWER -High ##.

  • Cardiovascular Disease
  • World
  • Market Size
  • Amgen Inc.
  • Celgene Corporation
  • 7.1.5 RISING PREVALENCE OF CARDIOVASCULAR DISEASE
  • 7.1 Growth Drivers

Figure ##: Global Number of Cancer Patients, 2015-2035 (Million) Source: World Economic Forum ##. ## ##. ## ##. ## ##. ## ##. ## ## ## ## ## ## ## ## 2015 2020 2025 2030 2035 Million ##. ##. ## RISING PREVALENCE OF CARDIOVASCULAR DISEASE ##. ## Growth Drivers The global growth rate of

  • Cardiovascular Disease
  • World
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Prevalence of cardiovascular disease in Brazil, In Billion
  • Prevalence of cardiovascular diseases in APAC region, In million

According to the company reports, Fagron' s branches in Europe are situated at the Netherlands (##), Belgium (##), Denmark (##), Germany (##), France (##), Italy (##), Greece (##), Coratia (##), Poland (##), Spain (##), Czech Republic (##) and

  • Cardiovascular Disease
  • Specialty Store
  • World
  • Market Size
  • Clinigen Group plc
  • TOTAL NUMBER OF PEOPLE IN NORTH AMERICA WITH DIFFERENT TYPE OF CARDIOVASCULAR DISEASE IN 2018

ONE OF THE OPTION IS TO USE THE SERVICES PROVIDED BY THE CONTRACT MANUFACTURING ORGANISATIONS.

  • Cardiovascular Disease
  • Pharmaceutical
  • World
  • Boehringer Ingelheim GmbH
  • Lonza Group Ltd
  • Cardiovascular Diseases: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
  • Transdermal Drug Delivery System Market, by Application, 2019 and 2027 (%)

Cardiovascular disease is one of the significant causes of death in Argentina.

  • Cardiovascular Disease
  • North America
  • Forecast
  • Hisamitsu Pharmaceutical Co., Inc.
  • Luye Pharma Group Ltd.
  • Prevalence of cardiovascular diseases in Germany, (In %)
  • Prevalence of cardiovascular disease in Brazil, In million

High investment for start-up. ##.

  • Breast Cancer
  • Cardiovascular Disease
  • North America
  • World
  • Hitachi, Ltd.
  • 5.3.1 Cardiovascular Disease
  • Cardiovascular Disease Therapeutics, Global,

Available from: http:/ / www. world-heartfederation. org/ press/ fact-sheets/ cardiovascular-disease-riskfactors/ [Accessed on June ##, 2017] WHO (2017).

  • Cardiovascular Disease
  • Amgen Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • 8.5 CARDIOVASCULAR DISEASES
  • 8.5.2 Cardiovascular Diseases: Pharmaceutical Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

Germany is one of the largest markets in Europe with over ## billion euros market share.

  • Cardiovascular Disease
  • Forecast
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • INCREASING PREVALENCE OF CARDIOVASCULAR DISEASE
  • 4.5 IMPACT ANALYSIS

According to the World Economic Forum in 2017, ## in ## deaths in the UAE is due to cardiovascular disease.

  • Cardiovascular Disease
  • World
  • Forecast
  • Market Size
  • Medtronic, Inc.
  • 8.3 CARDIOVASCULAR DISEASES TREATMENT MARKET
  • GLOBAL CARDIOVASCULAR DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

Approximately ##, ## Americans die of cardiovascular disease per year and an average of one death is recorded in every ## seconds.

  • Cardiovascular Disease
  • World
  • Forecast
  • Market Size
  • Medtronic, Inc.
  • GLOBAL CARDIOVASCULAR DISEASE PREVALENCE,
  • No.

Adhesives and ##.

  • Cardiovascular Disease
  • Chemical
  • World
  • Market Size
  • Baxter International Inc.
  • CARDIOVASCULAR DISEASE: CLINICAL TRIALS
  • BY APPLICATION [CARDIOVASCULAR DISEASE, NEUROLOGICAL

## ## What happened?

  • Cardiovascular Disease
  • United States
  • World
  • Forecast
  • Market Size
  • 4.5 Impact Analysis
  • 3.4 Expert Opinions

It also mentioned that one in ## deaths in men and one third deaths in women are due to cardiovascular disease.

  • Cardiovascular Disease
  • World
  • Forecast
  • Market Size
  • LivaNova PLC
  • 5.5 Impact Analysis of Drivers and Restraints
  • 10.1.9.2 Mexico: Bovine Pericardial Valve Market, by Valve Type, 2018-2027 (USD Million)

The valve helps for the blood flow from one chamber of heart to another one.

  • Cardiovascular Disease
  • United States
  • Forecast
  • Market Size
  • Boston Scientific Corporation
  • ALERE - MERGER & ACQUISITION, 2007 - 2017
  • 11.1 CARDIOVASCULAR TESTING

China has one of the highest CVD death rates in the world and it is estimated that one in ## adults in China has a cardiovascular disease (Source: American Heart Association).

  • Cardiovascular Disease
  • Abbott Laboratories, Inc.
  • Alere Inc.
  • Beckman Coulter, Inc.
  • CardioGenics Holdings Inc.
  • DISTRIBUTION OF CARDIOVASCULAR DISEASE DEATHS, 2015 (IN %)
  • According to European Cardiovascular Diseases Statistics 2017, each year cardiovascular disease (CVD) causes 3.9 million

About one in four men and nearly one in five women age ## to ## has high blood pressure.

  • Cardiovascular Disease
  • North America
  • World
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc

EXECUTIVE SUMMARY ##.

  • Cardiovascular Disease
  • Cholesterol
  • Chronic Disease
  • United States
  • World